Results 21 to 30 of about 3,002,254 (310)

Cluster randomized trial in the general practice research database: 2. Secondary prevention after first stroke (eCRT study): study protocol for a randomized controlled trial. [PDF]

, 2012
BACKGROUND: The purpose of this research is to develop and evaluate methods for conducting pragmatic cluster randomized trials in a primary care electronic database.
Wolfe Charles, Van Staa, Tjeerd; id_orcid, van Staa, Tjeerd, Mcdermott Lisa, Judith Charlton, Gulliford, Martin, Gerard McCann, Charlton, Judith, Ashworth Mark, Ashworth, Mark, Dregan Alex, McCann, Gerard, Charlton Judith, Anthony Rudd, Rudd Anthony, Lucy Yardley, Mark Ashworth, Gulliford Martin, Dregan, Alex; id_orcid, McCann Gerard, Lisa Mcdermott, Martin Gulliford, Tjeerd van Staa, Dregan, Alex, Yardley, Lucy, ?, ?, McDermott, Lisa, van Staa Tjeerd, null null, Wolfe, Charles, Yardley Lucy, Rudd, Anthony, eCRT Research Team, Charles Wolfe, Alex Dregan   +34 more
core   +1 more source

Stroke Prevention

Delaware Journal of Public Health, 2023
Stroke has three main subtypes - ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. The most common stroke subtype is ischemic stroke, making up about 88% of strokes. Many of these strokes may be prevented by lifestyle modifications.
openaire   +2 more sources

Nutrition and Stroke Prevention [PDF]

Stroke, 2006
Nutrition is much more important in prevention of stroke than is appreciated by most physicians. The powerful effects of statin drugs in lowering the levels of fasting cholesterol, combined with an unbalanced focus on fasting lipids (as opposed to postprandial fat and oxidative stress), have led many physicians and patients to believe that
Marc Fisher, Kennedy Lees, J. David Spence   +2 more
openaire   +4 more sources

Inflammation and Stroke Risk: A New Target for Prevention.

Stroke, 2021
New therapeutic approaches are required for secondary prevention of residual vascular risk after stroke. Diverse sources of evidence support a causal role for inflammation in the pathogenesis of stroke.
P. Kelly, R. Lemmens, G. Tsivgoulis
semanticscholar   +1 more source

Interventions Targeting Racial/Ethnic Disparities in Stroke Prevention and Treatment

Stroke, 2020
Systemic racism is a public health crisis. Systemic racism and racial/ethnic injustice produce racial/ethnic disparities in health care and health.
D. Levine, P. Duncan, Mai N. Nguyen-Huynh, Olugbenga Ogedegbe   +3 more
semanticscholar   +1 more source

Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010 : findings from the Global Burden of Disease Study 2010 [PDF]

, 2013
Funding: Bill & Melinda Gates Foundation.Background: The burden of ischaemic and haemorrhagic stroke varies between regions and over time. With differences in prognosis, prevalence of risk factors, and treatment strategies, knowledge of stroke ...
Dis, GB, Bennett, DA, Lawes, C.M.M., Anderson, L., Prof. Ralph L Sacco, MD, Thomas Truelsen, MD, Naghavi, Mohsen, Mensah, George A, Murray, C, Prof. Mohsen Naghavi, MD, Wenzhi Wang, PhD, Witt, Emma, Ezzati, M, Witt, E, Anderson, Laurie M., Mensah, G.A., Shinohara, Yukito, Mensah, GA, Feigin, VL, Anderson, LM, Feigin, Valery L, O'Donnell, M., Krishnamurthi, R, Krishnamurthi, R.V., Sacco, Ralph L, Prof. Mohammad H Forouzanfar, MD, Sacco, R.L., Prof. Valery L Feigin, MD, Bennett, D.A., O'Donnell, Martin, Ezzati, Majid, 2010, RFS2G, Krishnamurthi, Rita, Moran, AE, Krishnamurthi, Rita V, Naghavi, M, Forouzanfar, Mohammad H, A Mensah, George, Wang, W, Anderson, Laurie, Ezzati, M., Derrick A Bennett, PhD, Anderson, L, M Anderson, Laurie, Connor, Myles, Forouzanfar, MH, Truelsen, T., Moran, A.E., M M Lawes, Carlene, Emma Witt, MSc, Anderson, Laurie M, Truelsen, T, Wang, Wenzhi, H Forouzanfar, Mohammad, E Moran, Andrew, Lawes, CMM, L Feigin, Valery, Krishnamurthi, R., Barker-Collo, S., Forouzanfar, M.H., Narayanaswamy Venketasubramanian, MBBS, Murray, C., Bennett, Derrick, Prof. Majid Ezzati, PhD, Carlene M M Lawes, MBChB, Venketasubramanian, N, Bennett, Derrick A, Rita V Krishnamurthi, PhD, Sacco, RL, Shinohara, Y, Krishnamurthi, RV, Naghavi, M., Venketasubramanian, Narayanaswamy, Lawes, Carlene M M, Feigin, V.L., Witt, E., Connor, M, O'Donnell, M, Barker-Collo, S, GBD Stroke Experts Group, Moran, Andrew E, Prof. Suzanne Barker-Collo, PhD, Laurie M Anderson, PhD, L Sacco, Ralph, O’Donnell, Martin, Truelsen, Thomas, Murray, Christopher, The Lancet Global Health. Volume 1, Issue 5, November 2013, Pages e259–e281, Prof. Andrew E Moran, MD, Barker-Collo, Suzanne, Venketasubramanian, N., Grp, GSE, A Bennett, Derrick, Lawes, CM, Prof. Martin O'Donnell, PhD, Yukito Shinohara, MD, Myles Connor, MBBCh, V Krishnamurthi, Rita, George A Mensah, MD, Wang, W., Connor, M., Shinohara, Y., Prof. Christopher Murray, MD   +102 more
core   +1 more source

Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association

Circulation, 2018
Each chapter listed in the Table of Contents (see next page) is a hyperlink to that chapter. The reader clicks the chapter name to access that chapter. Each chapter listed here is a hyperlink.
E. Benjamin, S. Virani, C. Callaway, A. Chamberlain, Alexander R. Chang, Susan Cheng, Stephanie E. Chiuve, M. Cushman, F. Delling, R. Deo, S. D. de Ferranti, Jane F. Ferguson, M. Fornage, C. Gillespie, C. Isasi, Monik Jiménez, L. Jordan, S. Judd, D. Lackland, J. Lichtman, L. Lisabeth, Simin Liu, C. Longenecker, P. Lutsey, J. Mackey, D. Matchar, K. Matsushita, M. Mussolino, K. Nasir, M. O’Flaherty, L. Palaniappan, A. Pandey, D. Pandey, M. Reeves, M. Ritchey, C. Rodriguez, Gregory A. Roth, W. Rosamond, Uchechukwu Sampson, G. Satou, Svati H. Shah, N. Spartano, D. Tirschwell, C. Tsao, Jenifer H. Voeks, J. Willey, J. Wilkins, Jason H. Y. Wu, Heather M. Alger, Sally S. Wong, P. Muntner   +50 more
semanticscholar   +1 more source

Effects of Triflusal and Clopidogrel on the Secondary Prevention of Stroke Based on Cytochrome P450 2C19 Genotyping [PDF]

, 2017
BACKGROUND AND PURPOSE: To compare the efficacy and safety of antiplatelet agents for the secondary prevention of ischemic stroke based on cytochrome P450 2C19 (CYP2C19) polymorphisms.
김윤남, 이경아, 이경열, 남효석   +3 more
core   +1 more source

Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis

Stroke, 2020
Supplemental Digital Content is available in the text. Background and Purpose— The PCSK9 (proprotein convertase subtilisin-kexin type 9) monoclonal antibody evolocumab lowered LDL (low-density lipoprotein) cholesterol by 59% to 0.8 (0.5–1.2) mmol/L and ...
R. Giugliano, T. Pedersen, J. Saver, P. Sever, A. Keech, E. Bohula, S. Murphy, S. Wasserman, Narimon Honarpour, Hong Wang, Armando Lira Pineda, M. Sabatine   +11 more
semanticscholar   +1 more source

Stroke Prevention [PDF]

Stroke, 2020
In 44 years of practicing stroke prevention, I have learned many lessons; in this article, I hope to impart some of them. Three areas of my research are discussed. Controlling resistant hypertension is markedly improved by physiologically individualized therapy based on renin/aldosterone phenotyping; this is particularly important in black patients ...
openaire   +4 more sources